News

ATCC has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract (number 75N93025D00017) with an ordering period of 7 years with Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS). The contract, with an initial …

ivWatch, the IV safety company, has partnered with Aon, a leading global insurance broker and risk consultant, to quantify the clinical and financial impact of severe IV infiltration and extravasation injuries – one of the most underreported and costly adverse events in healthcare – and to model the return on investment associated with detecting these …

The life sciences industry is entering one of its most dynamic periods of innovation and expansion. Breakthroughs in biologics, advanced therapies, and drug-device combination products are reshaping the way medicines are developed, manufactured, and delivered to patients. With these scientific advances comes a new level of complexity. Companies must navigate increasingly sophisticated technologies, evolving regulatory …